2 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
Follow SAR405838: new trials by email Literature Review of SAR405838 trials Research Report on SAR405838
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Safety and Efficacy Study of SAR405838 and Pimasertib in Cancer Patients SAR405838, Pimasertib - Neoplasm Malignant | Phase 1 | Completed | Sanofi | 26 | 2013-11-01 | 2016-02-25 |
| Phase 1 Safety Testing of SAR405838 SAR405838 - Neoplasm Malignant | Phase 1 | Completed | Sanofi | 77 | 2012-07-13 | 2018-05-17 |
Neoplasms (2)
Sanofi (2)
France (2) · Netherlands (2) · United States (1)